Literature DB >> 15149148

Patients with Paget disease of nipple and with palpable mass in breast have unfavorable prognosis.

J Piekarski1, A Jeziorski, M Baklinska, W Szymczak, M Zadrozny, J Berner.   

Abstract

Recent data indicate that in breast cancer patients the presence of Paget disease of the nipple may be related to poor prognosis. Therefore, we decided to assess long-term results of the treatment of such patients, and to assess the relationship between the physical and pathological findings and prognosis. The files of 60 patients with Paget disease of the nipple who were treated between 1977 and 2000 were analyzed retrospectively with respect to the results of physical and pathologic examinations, disease recurrence and survival. In 38/60 patients, the cancer was invasive. In 26/60 patients, palpable masses in the breast were diagnosed. The 5-year overall survival probability was 0.68; the probability was 0.82 for patients without palpable masses, 0.51 for those with palpable masses, 0.91 for patients without invasive cancer and 0.58 for patients with associated invasive cancer. In conclusions, patients with Paget disease of the nipple and with palpable mass in the breast had unfavorable diagnosis. The nature of all nipple changes should be explained as early as possible in order to diagnose the disease when no mass is palpable in the breast.

Entities:  

Mesh:

Year:  2004        PMID: 15149148

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  2 in total

1.  Synchronous bilateral Paget's disease of the breast: A case report.

Authors:  Bojian Xie; Haihong Zheng; Huanrong Lan; Binbin Cui; Ketao Jin; Feilin Cao
Journal:  Oncol Lett       Date:  2012-04-11       Impact factor: 2.967

2.  Practical approach to extensive cutaneous spread without any underlying malignancy: a rare presentation of Paget's disease of breast.

Authors:  Kamal Kishore Lakhera; Sanjeev Patni; Nidhi Patni; Rohit Jindal
Journal:  BMJ Case Rep       Date:  2020-04-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.